NASDAQ:ETTX

Entasis Therapeutics Earning Date

USA |NASDAQ |USD

ETTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.30 $-0.29 $-0.37
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $0.00 $0.00 $0.00

Entasis Therapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

ETTX Earnings Date & History Chart

ETTX Earnings & Revenue Forecast

ETTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.31 $-0.44 $-0.24
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-1.18 $-1.40 $-1.07
Dec 2022 5 $-1.16 $-1.44 $-0.87

ETTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.31 $-0.14 $-0.12
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.18 $-1.06 $-1.06
Dec 2022 0 / 3 $-1.02 $-1.09 $-1.12

ETTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Dec 2022 5 $540.00K $0.00 $2.70M

ETTX Earnings Date & Revenue History

ETTX Earnings History

|
Show More
Show More

ETTX Revenue History

|
Show More
Show More

Entasis Therapeutics Next Earnings Date & Report

ETTX Next Earnings Date & Report Preview: Sep 2021 (FQ)

ETTX's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 5 analysts, the average EPS estimation for Entasis Therapeutics's next quarterly earnings is $-0.30, with a low EPS estimation of $-0.38, and a high estimation of $-0.25.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.30, the last 2 month trend is $-0.31, and the 3 month trend is $-0.31.

Based on 5 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Entasis Therapeutics Previous Earnings Dates & Reports

ETTX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Entasis Therapeutics's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.

ETTX's earnings per share (EPS) was $-0.29, beating the consensus analysts forecast of $-0.35 by 17.92%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 0.00%, and higher than the same period a year before (Jun 2020) by -62.82%.

Revenues were $0.00.

The company reported a net income of $-12.03M.

Free cash flow for the quarter was $-8.51M , compared to $-10.11M last quarter and $-11.00M a year before.

ETTX ended the quarter with $1.02M in total debt, a decrease of -13.04% compared to the previous quarter, and a decrease of -36.13% compared to the same quarter a year before.

ETTX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Entasis Therapeutics's previous annual earnings date was Mar 23, 2021 for its fiscal year ended Dec 31, 2020.

ETTX's earnings per share (EPS) was $-2.43, missing the consensus analysts forecast of $-2.39 by 1.67% , and higher than the previous year's EPS (Dec 2019) by -27.25%.

Revenues were $0.00.

The company reported a net income of $-50.50M.

Entasis Therapeutics reported a free cash flow of $-45.44M for its fiscal year, compared to $-44.85M a year ago.

The company ended the fiscal year with $1.32M in total debt, a decrease of -27.70% compared to the previous year.